Month: August 2020
We need a COVID vaccine. We also need to figure out how to get it to people
| Fortune

Good afternoon, readers. I’m moving to the opposite side of the country in a few days after 12 years on the East Coast. I plan to come back to New York one day—but I don’t know when. I’ve booked a one-way ticket to Southern California and am going to stay with my parents and little […]

Positive Results From An Alzheimer’s Clinical Trial
| HPR

Dr. RJ Tesi, CEO of INmune Bio, Inc., a clinical stage immuno-oncology company targeting neuroinflammation to fight brain disease, discusses positive data presented at The Alzheimer’s Association International Conference® 2020 from its XPro1595 Phase 1b Clinical Trial in Alzheimer’s disease patients. These data showed the anti-inflammatory effects of XPro1595 on neuroinflammation in the arcuate fasciculus (AF) […]

Why Covaxx thinks it has a COVID-19 vaccine game changer on its hands
| Fortune

We often take vaccines for granted: “Yes, of course I need to get my shots, and those shots will be available.” But vaccine development isn’t magic. It’s science and—especially during a pandemic—logistics. The coronavirus crisis has led to a veritable gold rush (and what some may call an arms race) in the biopharmaceutical industry. One company […]